The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
All content for Transforming Biopharma is the property of ZS and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
Transforming Biopharma
50 minutes
6 months ago
‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman to talk about how UCB has focused on simplifying its digital strategy to address key pain points for rare disease patients. Highlights include: Why partnerships are an important part of this journeyHow a collaboration using ZS’s ZEBRA tool helped UCB move the needle of diagnosisWhy pharma leaders should experiment with...
Transforming Biopharma
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discuss the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes. Highlights include: The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transp...
